AI models fuse multi-omics data to predict immunotherapy response in cancer
A narrative review in Cancer Cell International outlines how artificial intelligence can integrate genomic, transcriptomic, imaging, and other multi-omics data ...
A narrative review in Cancer Cell International outlines how artificial intelligence can integrate genomic, transcriptomic, imaging, and other multi-omics data ...
An editorial reviewing 15 studies finds that single-cell, spatial, metabolic, epigenetic and imaging methods expose cellular ecosystems associated with metastatic ...
A review finds that fungal compounds can suppress tumour growth, alter immunity and limit metastasis in skin-cancer models, but manufacturing, ...
A prespecified interim analysis of the phase 3 HARMONi-2 trial shows ivonescimab achieved median overall survival of 30.8 months versus ...
New research links the lipid-binding protein OSBPL3 to colorectal cancer progression, gut microbiota shifts, and immune microenvironment changes, with two ...
A case report describes a child with B-ALL who recovered from probable blinatumomab-associated lung injury and completed a monitored, dose-escalated ...
A new Oncotarget case report details how the WIN Consortium's international molecular tumor board evaluated investigational EGFR, MDM2, CDK4/6 and ...
A retrospective cohort study of 194 patients with esophageal squamous cell carcinoma found that postoperative pathological lymph node stage, rather ...
An exploratory multicenter biomarker analysis shows that pretreatment plasma lncRNA RIME, especially when combined with PD-L1, distinguishes patients with advanced ...
Updated Phase 3 DUO-E trial results presented at ESMO 2026 show that durvalumab plus olaparib after chemotherapy achieved a median ...
© 2025 Scienmag - Science Magazine
© 2025 Scienmag - Science Magazine